Sulfuric Acid

Sulfuric Acid

SCHEMBL27263282

ClC(Cl)Cl.O=S(=O)([O-])[O-].[Na+].[Na+]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
TP53 P04637 1/20 0.39
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL6765392 0.91 TP53 (0.39) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL9461728 0.80
Sulfuric Acid SCHEMBL29132022 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL11430373 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL7891773 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL29020604 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL7334619 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL412 0.80
Sulfuric Acid SCHEMBL1420915 0.80 ALDH1A1 (0.60) MEN1ALDH1A1TSHRKMT2ATP53
Sulfuric Acid SCHEMBL216020 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106575704-B Electronic device and compound 诺瓦尔德股份有限公司 2019-10-18 CN disclosed
CN-105037259-B The preparation method of pyranone and Pyridione derivatives 盐野义制药株式会社 2018-03-13 CN disclosed
CN-104230795-B The preparation method of pyranone and Pyridione derivatives 盐野义制药株式会社 2017-09-26 CN disclosed
CN-103896921-B As compound and the composition of kinases inhibitor IRM LLC (BM) 2016-02-24 CN disclosed
CN-103896921-A Compounds and compositions as protein kinase inhibitors NOVARTIS AG 2014-07-02 CN disclosed
CN-102725283-B Compounds and compositions as protein kinase inhibitors IRM LLC 2014-02-26 CN disclosed
CN-103221072-A In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents IMMUNOMEDICS INC 2013-07-24 CN disclosed
CN-101889010-B Isoxazolo-pyridine derivatives HOFFMANN LA ROCHE 2012-12-05 CN disclosed
CN-101233099-B Process for producing monosubstituted alkylated compound using aldimine or derivative thereof NAGASE & CO LTD 2012-11-28 CN disclosed
CN-102725283-A Compounds and compositions as protein kinase inhibitors IRM LLC 2012-10-10 CN disclosed
CN-1059725-A Novel methotrexate derivatives CHUGAI PHARMACEUTICAL CO LTD (JP) 1992-03-25 CN disclosed
CN-1013111-B The method for preparing Benzazecin derivative HOFFMANN LA ROCHE (CH) 1991-07-10 CN disclosed
CN-1011507-B PROCESSES FOR PREPARING 1,3-OXAZOLIDINE-2-ONE DERIVATIVES NIPPON CHEMIPHAR CO (JP) 1991-02-06 CN disclosed
CN-1042540-A The method for preparing Benzoheterocyclic compounds OTSUKA PHARMA CO LTD (JP) 1990-05-30 CN disclosed
CN-1035847-A The method for preparing optically active 2-aryl propionic acid RHONE POULENC SANTE (FR) 1989-09-27 CN disclosed
CN-1033996-A New quinoline and their preparation method DAINIPPON PHARMACEUTICAL CO (JP) 1989-07-19 CN disclosed
CN-87103953-A Pharmaceutically active 1, 5-diaryl-3-substituted pyrazoles and synthesis method thereof 1987-12-09 CN disclosed
CN-87100312-A Benzacyclodecane derivatives 1987-09-09 CN disclosed
CN-86108626-A Phenylformic acid and benzoate derivatives with anti-inflammatory and pain palliation efficacy 1987-07-22 CN disclosed
CN-85104606-A The method of preparation 1,3  oxazolidin-2-ketone derivatives 1986-12-24 CN disclosed